Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial (vol 389, pg 67, 2017)

Balar A. V; Galsky M. D.; Rosenberg J. E.

首页> 外文期刊>The Lancet >Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial (vol 389, pg 67, 2017)

【24h】

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial (vol 389, pg 67, 2017)

机译：atezolizumab作为顺铂型型患者局部晚期和转移性尿路上皮癌的一线治疗：单臂，多期，第2期试验（第389卷，PG 67,2017）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Lancet》 |2017年第10097期|共1页
作者
Balar A. V; Galsky M. D.; Rosenberg J. E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. CMAB009联合伊立替康或伊立替康单药二线治疗氟嘧啶和奥沙利铂治疗失败的KRAS野生型转移性结直肠癌患者的研究:一项前瞻性、开放、随机、Ⅲ期试验 [J] . 石远凯, 白丽, 张沂平, 癌症（英文版） . 2020,第007期
2. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial (vol 389, pg 67, 2017) [J] . Balar A. V, Galsky M. D., Rosenberg J. E. The Lancet . 2017,第10097期

机译：atezolizumab作为顺铂型型患者局部晚期和转移性尿路上皮癌的一线治疗：单臂，多期，第2期试验（第389卷，PG 67,2017）
3. Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed following Treatment with Platinum-Based Chemotherapy: A Single-Arm, Multicentre, Phase 2 Trial [J] . Chang Sam S. The Journal of Urology . 2016,第6期

机译：回复：Atezolizumab在铂类化疗治疗后进展为局部晚期转移性尿路上皮癌的患者中：单臂，多中心，2期试验
4. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study [J] . Balar Arjun V., Castellano Daniel, ODonnell Peter H., The lancet oncology . 2017,第11期

机译：第一线Pembrolizumab在顺铂 - 不合格患者患有局部晚期和不可切除或转移性尿路上皮癌症（Keynote-052）：多期，单臂，第2期研究
5. Integration of Surgery and Systemic Therapy in the Treatment of Locally Advanced and Metastatic Renal Cell Carcinoma [C] . Christopher G. Wood Genitourinary Cancers Symposium . 2011

机译：外科和全身治疗在局部晚期和转移性肾细胞癌中的整合
6. Atezolizumab as first-line therapy in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm multicentre phase 2 trial [O] . Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, -1

机译：Atezolizumab作为不适合顺铂治疗的局部晚期和转移性尿路上皮癌患者的一线治疗：一项单臂多中心2期试验
7. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [O] . Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, 2017

机译：atezolizumab作为顺铂型职有患者的一线治疗局部晚期和转移性尿路上皮癌：单臂，多期，第2期试验

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial (vol 389, pg 67, 2017)

著录项

相似文献

相关主题

期刊订阅